Royce & Associates’s Xperi XPER Stock Holding History

Royce & Associates’s Portfolio XPER Stock Details XPER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-534,313	Closed	-$4.23M	–	836
2025 Q2	$4.23M	Buy	534,313 +141,080	+36%	+$1.06M	0.04%	492
2025 Q1	$3.04M	Buy	+393,233	New	+$3.44M	0.03%	525

Other funds holding XPER

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates's XPER Position: Q3 2025 in Review

Royce & Associates sold out of Xperi (XPER) in Q3 2025, closing a stake of 534,313 shares — an estimated $4.23M sold.

Royce & Associates first reported a position in XPER in Q1 2025 and held it in 2 quarters. The position peaked at $4.23M in Q2 2025. 143 funds tracked by Wall St. Rank hold XPER as of Q3 2025.

Royce & Associates reported no remaining Xperi position as of Q3 2025 after selling out during the quarter.
Royce & Associates sold 534,313 Xperi shares in Q3 2025, an estimated $4.23M.
Royce & Associates first reported a position in Xperi in Q1 2025 and held it in 2 quarters.
Royce & Associates's Xperi position peaked at $4.23M in Q2 2025.
143 funds tracked by Wall St. Rank held Xperi as of Q3 2025.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.